Dr. Danilov earned his medical degree and PhD in Physiology in Russia. He is a physician-scientist with background in molecular biology and oncologic drug development and expertise in cancer cell signaling. He leads an independent research program in hematologic malignancies which bridges the understanding of B-cell biology with early clinical evaluation of novel therapeutics.
Alexey Danilov MD, PhD
Beckman Research Institute of the City of Hope
Duarte, California
United States
Project Title
Overcoming ibrutinib resistance in mantle cell lymphoma Enhancing efficacy of cyclin-dependent kinase inhibitors in diffuse large B-cell lymphoma
Program
Career Development Program
Translational Research Program